Literature DB >> 32619135

MiR-216a-3p regulates the proliferation, apoptosis, migration, and invasion of lung cancer cells via targeting COPB2.

Xiaolin Wang1, Jialun Shi1, Zhigao Niu1, Jianwu Wang1, Wenping Zhang1.   

Abstract

Effect of miR-216a-3p on lung cancer hasn't been investigated. Here, we explored its effects on lung cancer. MiR-216a-3p expression in lung cancer tissues and cells was detected by RT-qPCR. The target gene of miR-216a-3p was predicted by bioinformatics and confirmed by luciferase-reporter assay. After transfection, cell viability, migration, invasion, proliferation, and apoptosis were detected by MTT, scratch, transwell, colony formation, and flow cytometry. The expressions of COPB2 and apoptosis-related factors were detected by RT-qPCR or western blot. MiR-216a-3p was low-expressed and COPB2 was high-expressed in lung cancer tissues and cells. MiR-216a-3p targeted COPB2 and regulated its expression. MiR-216a-3p inhibited lung cancer cell viability, migration, invasion, and proliferation, while promoted apoptosis. Effect of miR-216a-3p on lung cancer was reversed by COPB2. MiR-216a-3p regulated proliferation, apoptosis, migration, and invasion of lung cancer cells via targeting COPB2.

Entities:  

Keywords:  COPB2; Lung cancer; miR-216a-3p; proliferation migration

Mesh:

Substances:

Year:  2020        PMID: 32619135     DOI: 10.1080/09168451.2020.1783197

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  9 in total

1.  Lysine demethylase 5A promotes prostate adenocarcinoma progression by suppressing microRNA-330-3p expression and activating the COPB2/PI3K/AKT axis in an ETS1-dependent manner.

Authors:  Yuanyuan Mi; Lifeng Zhang; Chuanyu Sun; Yanyan Feng; Jian Sun; Jun Wang; Dongjie Yang; Xiaowei Qi; Hongyuan Wan; Guowei Xia; Sheng Wu; Lijie Zhu
Journal:  J Cell Commun Signal       Date:  2022-05-18       Impact factor: 5.782

2.  Implication of COPB2 Expression on Cutaneous Squamous Cell Carcinoma Pathogenesis.

Authors:  Taiqin Chen; Ki-Yeol Kim; Yeongjoo Oh; Hei Cheul Jeung; Kee Yang Chung; Mi Ryung Roh; Xianglan Zhang
Journal:  Cancers (Basel)       Date:  2022-04-18       Impact factor: 6.575

3.  Circular RNA circRNA-0039459 promotes the migration, invasion, and proliferation of liver cancer cells through the adsorption of miR-432.

Authors:  Wenyong Zhou; Fengshuo Yang
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

4.  Circular RNA UBR1 promotes the proliferation, migration, and invasion but represses apoptosis of lung cancer cells via modulating microRNA-545-5p/SSFA2 axis.

Authors:  Peng Su; Feng Mao; Jian Zhang; Hui Zhang; MingBo Wang; YanZhao Xu; ZiQiang Tian
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

5.  MicroRNA Alterations Induced in Human Skin by Diesel Fumes, Ozone, and UV Radiation.

Authors:  Giuseppe Valacchi; Erika Pambianchi; Simona Coco; Alessandra Pulliero; Alberto Izzotti
Journal:  J Pers Med       Date:  2022-01-28

6.  miR-590-5p may regulate colorectal cancer cell viability and migration by targeting PDCD4.

Authors:  Ting Guo; Jun Wang; Guochang Cheng; He Huang
Journal:  Exp Ther Med       Date:  2020-09-04       Impact factor: 2.447

7.  Silencing the COPB2 gene decreases the proliferation, migration and invasion of human triple-negative breast cancer cells.

Authors:  Wencheng Wu; Chenyu Wang; Fengxia Wang; Yan Wang; Yanling Jin; Jing Luo; Min Wang; Chenli Zhang; Shuya Wang; Fangfang Zhang; Min Li
Journal:  Exp Ther Med       Date:  2021-05-24       Impact factor: 2.447

8.  Chrysin Induced Cell Apoptosis Through H19/let-7a/COPB2 Axis in Gastric Cancer Cells and Inhibited Tumor Growth.

Authors:  Lin Chen; Qirong Li; Ziping Jiang; Chengshun Li; Haobo Hu; Tiedong Wang; Yan Gao; Dongxu Wang
Journal:  Front Oncol       Date:  2021-06-03       Impact factor: 6.244

Review 9.  COPB2: a transport protein with multifaceted roles in cancer development and progression.

Authors:  Y Feng; X Lei; L Zhang; H Wan; H Pan; J Wu; M Zou; L Zhu; Y Mi
Journal:  Clin Transl Oncol       Date:  2021-06-08       Impact factor: 3.405

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.